2021 Lung Development, Injury and Repair Gordon Research Conference and Gordon Research Seminar

2021年肺发育、损伤与修复戈登研究会议暨戈登研究研讨会

• 批准号: 10217714
• 负责人: Daniel J. Tschumperlin
• 金额: $ 1万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-06-10 至 2022-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10217714
• 关键词: Address; Area; Asthma; Automobile Driving; Biological; Biology; Biomedical Engineering; COVID-19 pandemic; Career Mobility; Cells; Cellular biology; Cessation of life; Chronic; Chronic Obstructive Airway Disease; Chronic lung disease; Clinical; Collaborations; Data; Development; Diagnosis; Disabled Persons; Disease; Early Diagnosis; Ensure; Faculty; Fostering; Funding; Gender; Geography; Growth; Health; Injury; Investments; Long COVID; Lung; Lung diseases; Medicine; Mentors; Molecular; Molecular Biology; Physicians; Physiology; Population; Positioning Attribute; Postdoctoral Fellow; Pulmonary Fibrosis; Race; Research; Research Personnel; Role; SARS-CoV-2 infection; Scientist; Senior Scientist; Structure; Therapeutic; Time; Tissues; Translating; Translations; Underrepresented Minority; Viral; Woman; World Health Organization; career; cohort; experience; graduate student; human disease; injury and repair; knowledge integration; lung development; lung injury; meetings; next generation; novel; peer; peer networks; premature; pulmonary function; repaired; respiratory; restoration; severe injury; symposium; translational scientist

Project Summary: The 2021 Lung Development, Injury and Repair Gordon Research Conference (GRC) and associated Gordon Research Seminar (GRS) will be held August 14-20, 2021 in Waterville Valley, NH. The theme for the 2021 Lung GRC is "Biological Discoveries to Transform Respiratory Medicine". This meeting comes at a critical time, as the prolonged consequences of severe lung injuries associated with the COVID-19 pandemic will be coming into focus, heightening our need to understand, and ultimately counteract, the dysfunctional repair and remodeling that follows severe injury. Moreover, the growing global burden of lung disease continues unabated, with some 4 million premature deaths annually worldwide attributed to chronic respiratory diseases, including COPD, asthma, and pulmonary fibrosis, according to the World Health Organization. While investments in basic scientific research continue to accelerate substantial strides forward in understanding molecular, cellular and tissue level mechanisms driving respiratory diseases, translation of these findings toward early detection and effective repair and restoration of lung function in chronic respiratory diseases remains a major barrier. Meeting this challenge requires the integration of knowledge from experts spanning lung development, molecular and cell biology, physiology, bioengineering, matrix biology as well as physicians and translational experts immersed in the diagnosis and treatment of human disease. This conference will bring this diversity of expertise together to disseminate and debate the latest findings in the fields of lung development, injury and repair, and to formulate the new ideas, collaborations and approaches that will be needed to translate biologic discoveries toward meaningful advances in respiratory medicine. A major emphasis of the Lung GRC and GRS is to strengthen the pipeline of scientists and clinicians focused on lung development, injury and repair. Funds from this R13 will be specifically targeted to promote participation in the conference by women, under-represented minorities and people with disabilities, particularly graduate students, postdoctoral fellows, and early career investigators. The unique attributes of the GRC (small, secluded, unpublished data, abundant time for discussion) and GRS (close trainee interactions with peers and seniors) formats provide an opportunity for formal and informal interactions and collaborations that are likely to have significant and sustained impact on the field. The Lung Development, Injury and Repair GRC/GRS will thus promote accelerated progress in understanding and treating chronic lung diseases, and help to ensure the vitality and growth of a diverse pipeline of clinicians and scientists capable of addressing the growing burden of lung diseases.

项目概要： 2021年肺发育，损伤和修复戈登研究会议（GRC）和相关的戈登 研究研讨会（GRS）将于2021年8月14日至20日在沃特维尔山谷，NH举行。2021年的主题 肺GRC是“改变呼吸医学的生物发现”。这次会议是在一个关键时刻召开的， 由于与COVID-19大流行相关的严重肺损伤的长期后果即将到来， 聚焦，提高我们理解的需要，并最终抵消，功能失调的修复， 严重损伤后的重塑。此外，全球肺部疾病的负担仍在继续增加， 全球每年约有400万人因慢性呼吸道疾病而过早死亡， 包括慢性阻塞性肺病、哮喘和肺纤维化。而 对基础科研的投资继续加速认识的重大进步 分子、细胞和组织水平的机制驱动呼吸系统疾病，这些发现的转化 致力于慢性呼吸系统疾病的早期检测和有效修复及肺功能恢复 仍然是一个主要障碍。应对这一挑战需要整合来自不同领域的专家的知识， 肺发育，分子和细胞生物学，生理学，生物工程，基质生物学以及医生 以及致力于人类疾病诊断和治疗的翻译专家。本次大会将 将这种多样性的专业知识聚集在一起，传播和辩论肺部领域的最新发现， 发展，损伤和修复，并制定新的想法，合作和方法，将 需要将生物学发现转化为呼吸医学的有意义的进步。一个主要 肺GRC和GRS的重点是加强专注于肺的科学家和临床医生的管道 发育、损伤和修复。R13的资金将专门用于促进参与 妇女、代表人数不足的少数民族和残疾人，特别是研究生 学生、博士后研究员和早期职业调查人员。GRC的独特属性（小， 隐蔽的、未发表的数据、充足的讨论时间）和GRS（学员与同行的密切互动， 老年人）的形式提供了一个机会，正式和非正式的互动和合作，可能会 对实地产生重大和持续的影响。肺发育、损伤和修复GRC/GRS将 从而促进对慢性肺部疾病的理解和治疗的加速进展，并有助于确保 一个多样化的临床医生和科学家管道的活力和增长，能够解决日益增长的负担， 肺部疾病